Delivery Order SPE2DU25D2017-SPE2DU26FAD54
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,314.62 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 27, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $5,894.97 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 10, 2025, with an ultimate completion date of the same day. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $24,552.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical. The contract will be...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $13,212.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract action under AmerisourceBergen's larger relationship with the federal government. The work will be performed at the company's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $8,071.20 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 2, 2026, with an ultimate completion date of January 5, 2026. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The work is being performed at AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $550,102.16 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 11, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's existing indefinite delivery contract vehicle. The work will be performed at the company's corporate office in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,492.36 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 5, 2026, with an ultimate completion date of January 6, 2026. This firm fixed-price delivery order, which received no set-aside designation, was competitively awarded and represents a child order under AmerisourceBergen's larger contract vehicle. The work will be performed at the vendor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,509.00 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 2, 2026, with an ultimate completion date of January 5, 2026. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,835.16 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,656.60 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 2, 2026, with an ultimate completion date of January 5, 2026. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The performance location is the vendor's corporate office in Conshohocken,...
- SPE2DU25D2017Indefinite Delivery Contract
- SPE2DU25D2017-SPE2DU26FAD54Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,427.63 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price delivery order, issued without set-aside designation, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is structured to support the military healthcare supply chain by delivering pharmaceutical products and medical supplies to federal medical facilities. The work is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical support vehicle with DLA, valued at up to $999,999,999.00 through December 2026, which enables the company to supply a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs globally. AmerisourceBergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/7/26 |